GGrantIndex
← Search

TUMOR-SPECIFIC TH1/TH17 HYBRID IMMUNOTHERAPY AGAINST ESTABLISHED MELANOMA

$112,125FY2016Department of DefenseDOD

The Medical University Of South Carolina

Investigators

View source on USAspending →
TUMOR-SPECIFIC TH1/TH17 HYBRID IMMUNOTHERAPY AGAINST ESTABLISHED MELANOMA · GrantIndex